Director of Upstream MSAT & Process Development leading innovative treatments for serious diseases. Driving process development and managing upstream manufacturing in biopharmaceuticals.
SR
Scholar Rock
Currently Hiring
About the company
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
Our most advanced investigational product candidate, apitegromab (SRK-015), a
selective inhibitor of the activation of the growth factor myostatin in skeletal muscle, is in development for the treatment of spinal muscular atrophy, or SMA.
Following positive results from the TOPAZ Phase 2 trial in patients with Type 2 and Type 3 SMA, we are now advancing apitegromab development through SAPPHIRE, a randomized, double-blind, placebo-controlled, phase 3 clinical trial.
In addition, we are conducting our DRAGON Phase 1 proof-of-concept trial for SRK-181, a selective inhibitor of latent TGFβ1 activation, in patients with locally advanced and metastatic solid tumors.
Utilizing our proprietary platform, we are creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia.
Open jobs
Browse and apply for open jobs at Scholar Rock.
11 jobs found
Senior Director of Global Quality Control overseeing QC strategy for life - changing therapies in biopharmaceuticals. Leading external QC laboratories and ensuring compliance with global standards.
Senior Director of US Quality Assurance at Scholar Rock, a biopharmaceutical firm focused on innovative treatments. Leading quality assurance for external GxP biologics operations and partner governance.
Senior Accounting Manager managing monthly close process and leading finance operations in biopharmaceutical company. Ensuring compliance with SOX and external reporting requirements.
Director of KOL Engagement for biopharmaceutical company focused on innovative therapies. Building relationships with key opinion leaders for commercial launch of apitegromab in the U.S.
Senior Director responsible for U.S. HCP marketing strategy for apitegromab at Scholar Rock. Leading launch - phase efforts and collaborating with various teams within the organization.
Senior Director of Patient Marketing leading U.S. launch for apitegromab, the first muscle - targeted therapy for spinal muscular atrophy. Developing strategy and overseeing execution for patient engagement and education.
US Medical Director providing strategic leadership in medical affairs within the biopharmaceutical industry. Focusing on rare neuromuscular diseases like spinal muscular atrophy to improve patient outcomes.
Senior Director of Commercial Training at Scholar Rock designing disease and product education curriculums. Leading the commercial training team and driving engagement competencies for business success.
Director, Field Force Operations at Scholar Rock, advancing commercial operations in biotech. Managing sales sizing, compensation, and analytics across the organization.
Senior Clinical Trial Manager overseeing operational aspects of clinical studies at Scholar Rock. Implementing project plans and coordinating team activities throughout the study lifecycle.